DE602006009906D1 - Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform - Google Patents

Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform

Info

Publication number
DE602006009906D1
DE602006009906D1 DE602006009906T DE602006009906T DE602006009906D1 DE 602006009906 D1 DE602006009906 D1 DE 602006009906D1 DE 602006009906 T DE602006009906 T DE 602006009906T DE 602006009906 T DE602006009906 T DE 602006009906T DE 602006009906 D1 DE602006009906 D1 DE 602006009906D1
Authority
DE
Germany
Prior art keywords
magnesium carbonate
carbonate containing
heavy magnesium
dosing form
quickly resolving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006009906T
Other languages
English (en)
Inventor
Torfi E Kristjansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Group PTC ehf
Original Assignee
Actavis Group hf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group hf filed Critical Actavis Group hf
Publication of DE602006009906D1 publication Critical patent/DE602006009906D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DE602006009906T 2005-03-02 2006-03-02 Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform Active DE602006009906D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS7724A IS7724A (is) 2005-03-02 2005-03-02 Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
PCT/IS2006/000005 WO2006092812A2 (en) 2005-03-02 2006-03-02 Rapidly disintegrating dosage form comprising magnesium carbonate heavy

Publications (1)

Publication Number Publication Date
DE602006009906D1 true DE602006009906D1 (de) 2009-12-03

Family

ID=36922130

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602006009906T Active DE602006009906D1 (de) 2005-03-02 2006-03-02 Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform
DE202006020222U Expired - Lifetime DE202006020222U1 (de) 2005-03-02 2006-03-02 Schnell zerfallende Darreichungsform umfassend Magnesiumcarbonat schwer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE202006020222U Expired - Lifetime DE202006020222U1 (de) 2005-03-02 2006-03-02 Schnell zerfallende Darreichungsform umfassend Magnesiumcarbonat schwer

Country Status (9)

Country Link
US (1) US20080166406A1 (de)
EP (1) EP1863443B1 (de)
JP (1) JP2008531681A (de)
CN (1) CN101132764A (de)
AT (1) ATE446084T1 (de)
CA (1) CA2599308A1 (de)
DE (2) DE602006009906D1 (de)
IS (1) IS7724A (de)
WO (1) WO2006092812A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070298107A1 (en) * 2003-11-25 2007-12-27 Aurobindo Pharma Ltd. Pharmaceutical Compositions of Mirtazapine
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
WO2009118760A2 (en) * 2008-03-26 2009-10-01 Matrix Laboratories Limited Lanthanum composition
WO2009150665A1 (en) * 2008-06-09 2009-12-17 Lupin Limited Orally disintegrating pharmaceutical compositions of escitalopram and salts thereof
US8343978B2 (en) * 2008-08-04 2013-01-01 Adds Pharmaceuticals Llc Fast onset orodispersable tablets
EP2198857A1 (de) 2008-12-19 2010-06-23 Ratiopharm GmbH Orale dispergierbare Tablette
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
DE102009041839A1 (de) * 2009-09-18 2011-03-24 Dolorgiet Gmbh & Co. Kg Donepezil-haltige Tabletten
JP5614445B2 (ja) * 2010-03-29 2014-10-29 アステラス製薬株式会社 経口投与用粒子状医薬組成物
WO2011121824A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 口腔内崩壊錠
EP2377522B1 (de) * 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Formulierungen von im Mund zerfallenden Mirtazapintabletten und Herstellungsverfahren dafür.
US8906949B2 (en) * 2010-05-21 2014-12-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
WO2013172805A1 (en) * 2012-05-14 2013-11-21 Mahmut Bilgic New orodispersible tablet formulations of olanzapine
JP6062693B2 (ja) * 2012-09-14 2017-01-18 沢井製薬株式会社 オランザピン含有製剤
CN104640569A (zh) * 2012-09-18 2015-05-20 默克专利股份有限公司 在含活性成分的制剂中用作载体材料的碱式碳酸镁
CN104870018A (zh) * 2012-12-21 2015-08-26 默克专利股份有限公司 具有改善的活性物质的释放作为药物制剂中载体的碱式碳酸镁
CN103284969B (zh) * 2013-07-01 2015-05-27 南京正宽医药科技有限公司 一种利培酮分散片及其制备方法
CN103520169B (zh) * 2013-10-25 2015-07-15 山东鲁药制药有限公司 米氮平片及其制备方法
RS62844B1 (sr) 2015-06-18 2022-02-28 Estetra Srl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
CA2988498C (en) 2015-06-18 2022-02-08 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
JP2017014119A (ja) * 2015-06-26 2017-01-19 東和薬品株式会社 経口医薬組成物
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN111714463B (zh) * 2020-08-14 2022-06-17 华农（肇庆）生物产业技术研究院有限公司 米氮平口服剂及其制备方法
CN115252568A (zh) * 2022-08-26 2022-11-01 苏州中化药品工业有限公司 一种盐酸西替利嗪片剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2147743A (en) * 1938-08-05 1939-02-21 Baker Chem Co J T Pharmaceutical preparation
GB1422176A (en) * 1973-05-05 1976-01-21 Beecham Group Ltd Pharmaceutical tablets
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
CA2128820A1 (en) 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
WO1997038679A2 (en) 1996-04-16 1997-10-23 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
DK1736144T3 (en) 1998-05-18 2015-12-07 Takeda Pharmaceutical Orally disintegrating tablets.
US6635278B1 (en) * 1998-12-15 2003-10-21 Gilead Sciences, Inc. Pharmaceutical formulations
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CA2552221A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations

Also Published As

Publication number Publication date
ATE446084T1 (de) 2009-11-15
WO2006092812A2 (en) 2006-09-08
EP1863443A2 (de) 2007-12-12
JP2008531681A (ja) 2008-08-14
CN101132764A (zh) 2008-02-27
DE202006020222U1 (de) 2008-06-05
EP1863443B1 (de) 2009-10-21
WO2006092812A3 (en) 2006-12-21
US20080166406A1 (en) 2008-07-10
CA2599308A1 (en) 2006-09-08
IS7724A (is) 2006-09-03

Similar Documents

Publication Publication Date Title
DE602006009906D1 (de) Schweres magnesiumcarbonat enthaltende schnell auflösende dosierform
TW200716119A (en) A solid pharmaceutical dosage formulation
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
CA115125S (en) Electrode array
FR2893427B1 (fr) Systeme electrochimique sur plastique
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
BRPI0606145B8 (pt) formas farmacêuticas sólidas de cloridrato de oxicodona resistentes ao rompimento com liberação sustentada
EA200701918A1 (ru) Белок липокалин
AR053613A1 (es) Combinacion de compuestos activos fungicidas
BRPI0815578A2 (pt) Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo.
SV2006002296A (es) Tratamiento de mastitis ref. bhc041335-sv
USD672015S1 (en) Drainage grate frame
MA27889A1 (fr) Comprime contenant de la fluvastatine et de la carmellose calcique
AR059544A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas
EA201070393A1 (ru) Тупик трубопровода
CL2007002981A1 (es) Composicion farmaceutica que contiene 75 mg del isomero dextrogiro de clopidogrel y 300 mg de triflusal, util en el tratamiento de enfermedades tromboembolicas.
DE502006005592D1 (de) Transportvorrichtung mit verstaubarer rolleneinrichtung
CR8948A (es) Composicion farmaceutica
USD642253S1 (en) Diffusing evaporator of active substances
CA118203S (en) Straw chopper
RU2007144936A (ru) Гидроавтомат сифонного типа
AR055352A1 (es) Composicion farmaceutica
UA11029U (uk) Композиція для лікарського засобу
ES1059819Y (es) Televisor con dispositivo de gestion de contenidos.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ACTAVIS GROUP PTC EHF, HAFNARFJORDUR, IS

8364 No opposition during term of opposition